FDA pauses Regenxbio gene therapy trial again due to safety concerns
Five patients were found to have small masses on their spines. Regenxbio has faced previous safety concerns with its gene therapies.
News Search
Search results for FDA pauses Regenxbio gene therapy trial again due to safety concerns
Search Results
1 results found